Rituximab immunotherapy is associated with improvement of periodontal in subjects with rheumatoid arthritis.

Jacques-Olivier Pers; Juliette Coat; Julien Demoersman; Divi Cornec; Valérie Devauchelle-Pensec; Alain Saraux

Rituximab immunotherapy is associated with improvement of periodontal in subjects with rheumatoid arthritis.

Jacques-Olivier Pers ¹ Juliette Coat ¹ Julien Demoersman ¹ Divi Cornec ^{2, 1} Valérie Devauchelle-Pensec ^{1, 2} Alain Saraux ^{1, 2}

1 EA2216 - Immunologie et Pathologie

2 CHU - BREST - Rhumato - CHRU Brest - Service de Rhumatologie

Type de document :

Communication dans un congrès

10th International Congress on Autoimmunity , Apr 2016, Leipzig, Germany

Domaine :

Sciences du Vivant [q-bio] / Immunologie

Liste complète des métadonnées

http://hal.univ-brest.fr/hal-01296598
Contributeur : Geneviève Michel <>
Soumis le : vendredi 1 avril 2016 - 11:36:59
Dernière modification le : samedi 2 avril 2016 - 01:03:34

Rituximab immunotherapy is associated with improvement of periodontal in subjects with rheumatoid arthritis.

Identifiants

Collections

Citation

Exporter

Métriques

32

Contact

Rituximab immunotherapy is associated with improvement of periodontal in subjects with rheumatoid arthritis.

Identifiants

Collections

Citation

Exporter

Partager

Métriques

32

Contact